Factors Associated With Guideline-concordant and Excessive Cervical Cancer Screening: A Mixed Methods Study.
Rebecca B PerkinsLindsay FuzzellPaige LakeNaomi C BrownsteinHolly B FontenotAlexandra MichelAshley WhitmerSusan T VadaparampilPublished in: Women's health issues : official publication of the Jacobs Institute of Women's Health (2024)
Most clinicians screened with Pap/HPV cotesting and approximately one-half endorsed a 5-year screening interval. Clinician knowledge gaps include understanding the evidence underlying 5-year intervals and appropriate risk assessment to determine which patients should be screened more frequently. Education and tracking systems can promote guideline-concordant screening.